TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23972353

Group type: EXPERIMENTAL
Intervention: Acute pain during working memory test
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control condition (no pain)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Acute pain followed by working memory test 20 minutes after pain
Number of subjects: 78
Study: 22018365

Group type: EXPERIMENTAL
Intervention: Optimized axial length (AL) calculation method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard IOL power calculation formulas (Holladay 1, Haigis, SRK/T, Hoffer Q)
Number of subjects: 0
Study: 19392579

Group type: EXPERIMENTAL
Intervention: Naproxcinod (AZD3582)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 0
Study: 17445933

Group type: EXPERIMENTAL
Intervention: Insulin aspart with metformin 500 mg t.i.d. for 90 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: Human insulin with metformin 500 mg t.i.d. for 90 days
Number of subjects: 30
Study: 15600248

Group type: EXPERIMENTAL
Intervention: Maribavir (DNA synthesis inhibitor)
Number of subjects: 0
Study: 15899652

Group type: EXPERIMENTAL
Intervention: alpha-tocopherol (800 mg/day)
Number of subjects: 29

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 29
Study: 10602349

Group type: EXPERIMENTAL
Intervention: Low-saturated fat, low-cholesterol dietary intervention
Number of subjects: 202
Study: 8621850

Group type: EXPERIMENTAL
Intervention: Zileuton (600 mg orally four times a day for 8 days)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Zileuton
Number of subjects: 10
Study: 1742650

Group type: EXPERIMENTAL
Intervention: Threshold allergen dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher allergen dose (x 10 threshold)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7139396

Group type: EXPERIMENTAL
Intervention: d‐tubocurarine 0.04 mg.kg‐1 and atropine 0.01 mg.kg‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: d‐tubocurarine 0.04 mg.kg‐1 only
Number of subjects: 60

Group type: COMPARATOR
Intervention: No pretreatment
Number of subjects: 60
Study: 29524000

Group type: EXPERIMENTAL
Intervention: OLE in solution (25 g sucrose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: OLE in capsules or solution (50 g sucrose or glucose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: OLE (general use)
Number of subjects: 0
Study: 29703254

Group type: EXPERIMENTAL
Intervention: CRADLE Vital Sign Alert device and training package
Number of subjects: 204
Study: 27164511

Group type: EXPERIMENTAL
Intervention: IV dexketoprofen 50mg
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Paracetamol 1g
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Metamizol 1g
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 24531433

Group type: EXPERIMENTAL
Intervention: Contrast water therapy (alternating 1 minute 38° C and 1 minute 15° C water immersion)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Contrast showers (alternating 1 minute 38° C and 1 minute 18° C showers)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Passive recovery (seated rest in 20° C)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Contrast water therapy and contrast showers
Number of subjects: 10
Study: 21998061

Group type: EXPERIMENTAL
Intervention: CT hypodensities attributed to delayed ischemic neurological deficit
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Expert consensus on CT hypodensities
Number of subjects: 413

Group type: EXPERIMENTAL
Intervention: Interobserver variability in attributing CT hypodensities
Number of subjects: 413
Study: 20403600

Group type: EXPERIMENTAL
Intervention: Sedative music for 30 minutes
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (resting in bed)
Number of subjects: 126
Study: 18072989

Group type: EXPERIMENTAL
Intervention: ED staff ordered an exercise stress test for the intervention group.
Number of subjects: 231

Group type: COMPARATOR
Intervention: Control group advised to contact their family physician (FP) to arrange testing.
Number of subjects: 231
Study: 16266651

Group type: EXPERIMENTAL
Intervention: Simple spirometry conducted with an automatic, portable, dry spirometer.
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Cost of spirometry conducted by a doctor or nurse.
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Optimal cost scenario with a single nurse conducting spirometry.
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Two trained professionals conducting spirometry.
Number of subjects: 277
Study: 12047490

Group type: EXPERIMENTAL
Intervention: nabumetone 1000 mg twice daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: meloxicam 7.5 mg twice daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: indomethacin 50 mg
Number of subjects: 12
Study: 10069268

Group type: EXPERIMENTAL
Intervention: Happy mood manipulation
Number of subjects: 67

Group type: COMPARATOR
Intervention: Sad mood manipulation
Number of subjects: 67

Group type: COMPARATOR
Intervention: Neutral mood manipulation
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 67
Study: 7673658

Group type: EXPERIMENTAL
Intervention: Cyproheptadine augmentation of haloperidol
Number of subjects: 40

Group type: COMPARATOR
Intervention: Haloperidol with placebo
Number of subjects: 40
Study: 31878845

Group type: EXPERIMENTAL
Intervention: Mother-to-infant skin-to-skin contact for 30 minutes in the first postnatal hour
Number of subjects: 75

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 75
Study: 30691750

Group type: EXPERIMENTAL
Intervention: Therapeutic moist heat around the elbow
Number of subjects: 56

Group type: COMPARATOR
Intervention: No thermal agent (control)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Therapeutic cold around the elbow
Number of subjects: 56
Study: 29441909

Group type: EXPERIMENTAL
Intervention: Esmolol (0.3 mg/kg before intubation, continuous perfusion at 50 μg/kg/min during operation)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 60
Study: 25588713

Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 92

Group type: COMPARATOR
Intervention: Tacrolimus
Number of subjects: 92
Study: 24081158

Group type: EXPERIMENTAL
Intervention: recombinant human GH (rhGH) (33-50 μg kg(‐1) day(‐1))
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (Plc)
Number of subjects: 20
Study: 21920668

Group type: EXPERIMENTAL
Intervention: Group Cognitive Behavioral Therapy (CBT)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Group Education Intervention (EDU)
Number of subjects: 83
Study: 20084879

Group type: EXPERIMENTAL
Intervention: Booster dose of PCV7
Number of subjects: 488
Study: 16948824

Group type: EXPERIMENTAL
Intervention: Broad-band UVB phototherapy plus oral acyclovir (800 mg five times a day for 10 days); UVB starting at 20 mJ/cm², increasing by 10 mJ/cm² per session, max 100 mJ/cm², 3 times a week for up to 15 sessions.
Number of subjects: 25

Group type: COMPARATOR
Intervention: Oral acyclovir (800 mg five times a day for 10 days) only (control group).
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: UVB phototherapy for established PHN (more than 3 months after rash onset).
Number of subjects: 25
Study: 15256691

Group type: EXPERIMENTAL
Intervention: 6% carbohydrate ingestion (C; n = 23)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (P; n = 25)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: All subjects combined
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Young runners (<50 years)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Old runners (>=50 years)
Number of subjects: 48
Study: 11421836

Group type: EXPERIMENTAL
Intervention: Combination of droperidol 15 microg kg(‐1) and ondansetron 100 microg kg(‐1)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Ondansetron 150 microg kg(‐1)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Droperidol 25 microg kg(‐1)
Number of subjects: 240
Study: 9202616

Group type: EXPERIMENTAL
Intervention: Physical training (4 months, 5 days/week, 40 minutes/day)
Number of subjects: 35
Study: 8287811

Group type: EXPERIMENTAL
Intervention: 3% sodium tetradecyl sulphate (STD)
Number of subjects: 95

Group type: COMPARATOR
Intervention: 5% ethanolamine oleate (ETH)
Number of subjects: 95
Study: 3566859

Group type: EXPERIMENTAL
Intervention: Digoxin-Pharbita 0.25 mg (Product A)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Reference drug B (Product B)
Number of subjects: 10
Study: 31799993

Group type: EXPERIMENTAL
Intervention: Maintenance of Antidepressant Medication (ADM)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Antidepressant Medication (ADM) alone
Number of subjects: 292

Group type: COMPARATOR
Intervention: Phase 1 condition (ADM alone vs ADM plus CBT)
Number of subjects: 292
Study: 31428143

Group type: EXPERIMENTAL
Intervention: Posttraining alpha transcranial alternating current stimulation (alpha-tACS) targeting left M1 at 10 Hz
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Posttraining beta transcranial alternating current stimulation (beta-tACS) targeting left M1 at 20 Hz
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 0
Study: 28363586

Group type: EXPERIMENTAL
Intervention: 3% diquafosol ophthalmic solution
Number of subjects: 47

Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 47
Study: 25248345

Group type: EXPERIMENTAL
Intervention: Subunit Agrippal vaccine
Number of subjects: 110
Study: 24229408

Group type: EXPERIMENTAL
Intervention: Efficient algorithms for randomly expanding phylogenetic trees
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Algorithms for calculating distance matrices
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Source code implementation in C++
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Web service availability
Number of subjects: 0
Study: 21883001

Group type: EXPERIMENTAL
Intervention: Haematococcus astaxanthin (ASX) 5 mg
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Haematococcus astaxanthin (ASX) 20 mg
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Haematococcus astaxanthin (ASX) 40 mg
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (non-smokers)
Number of subjects: 39
Study: 19485993

Group type: EXPERIMENTAL
Intervention: Self-management programme (SMP) in addition to standard care
Number of subjects: 140

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 140
Study: 16428209

Group type: EXPERIMENTAL
Intervention: Early operation (within six weeks of initial assessment)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Delayed operation (within six months of recruitment)
Number of subjects: 73
Study: 12967073

Group type: EXPERIMENTAL
Intervention: Direct resin composite technique (SBMP++ Z100)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Open sandwich technique (Fuji II LC + SBMP++ Z100)
Number of subjects: 40
Study: 10630442

Group type: EXPERIMENTAL
Intervention: L. acidophilus LB
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 9360340

Group type: EXPERIMENTAL
Intervention: Oresol-R
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Oresol-F
Number of subjects: 437

Group type: COMPARATOR
Intervention: Oresol-G
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Oresol-K
Number of subjects: 437
Study: 1545961

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 21
Study: 3899198

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (Dex) 15 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Fenfluramine (Fen) 40 mg
Number of subjects: 16
Study: 29887334

Group type: EXPERIMENTAL
Intervention: Bevacizumab 0.25 mg
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Bevacizumab 0.125 mg
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Bevacizumab 0.063 mg
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Bevacizumab 0.031 mg
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Bevacizumab (all doses)
Number of subjects: 61
Study: 28258931

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lansoprazole
Number of subjects: 0
Study: 25704503

Group type: EXPERIMENTAL
Intervention: High dose MFGM tablets (6.5 g) for 4 weeks
Number of subjects: 32

Group type: COMPARATOR
Intervention: Whole milk powder for 4 weeks
Number of subjects: 32
Study: 23849431

Group type: EXPERIMENTAL
Intervention: Disulfiram (250 mg/day, N=32)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo (N=37)
Number of subjects: 69
Study: 21496770

Group type: EXPERIMENTAL
Intervention: Reflex Control(®) shoes (RC)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: MBT(®) shoes
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 29
Study: 18655523

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment at 0.067 mg/kg/day
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment at 0.033 mg/kg/day
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 67
Study: 16968587

Group type: EXPERIMENTAL
Intervention: Cefdinir (14 mg/kg divided BID)
Number of subjects: 318

Group type: COMPARATOR
Intervention: High-dose amoxicillin/clavulanate (90/6.4 mg/kg divided BID)
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Cefdinir
Number of subjects: 318

Group type: COMPARATOR
Intervention: High-dose amoxicillin/clavulanate
Number of subjects: 318
Study: 15523393

Group type: EXPERIMENTAL
Intervention: Surgical resection
Number of subjects: 42

Group type: COMPARATOR
Intervention: Radiochemotherapy (200 mg/m²/day of intravenous 5-fluorouracil and 5040 cGy of radiotherapy)
Number of subjects: 42
Study: 11515713

Group type: EXPERIMENTAL
Intervention: Willow bark extract (Assalix) 240 mg salicin per day (group W240)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Willow bark extract (Assalix) 120 mg salicin per day (group W120)
Number of subjects: 451

Group type: COMPARATOR
Intervention: Conventional treatments only (group C)
Number of subjects: 451
Study: 9791144

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg) plus Icatibant (100 microg/kg)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Losartan (75 mg)
Number of subjects: 27
Study: 7842496

Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Single case studies with randomized treatment
Number of subjects: 8
Study: 2922985

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Epidural morphine
Number of subjects: 22
Study: 30572467

Group type: EXPERIMENTAL
Intervention: Laser Analgesia (LA) using erbium-doped yttrium aluminium garnet (Er:YAG) laser
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo Analgesia (PA)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Laser Analgesia (LA)
Number of subjects: 41
Study: 27099247

Group type: EXPERIMENTAL
Intervention: Corticotropin-releasing factor (CRF) injection
Number of subjects: 21

Group type: COMPARATOR
Intervention: Saline injection (control)
Number of subjects: 21
Study: 24560674

Group type: EXPERIMENTAL
Intervention: Monovalent replication-deficient delNS1-H1N1 influenza virus vaccine (7.7log10TCID50/volunteer)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Monovalent replication-deficient delNS1-H1N1 influenza virus vaccine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nasal wash sample
Number of subjects: 12
Study: 22516692

Group type: EXPERIMENTAL
Intervention: AA genotype group
Number of subjects: 29

Group type: COMPARATOR
Intervention: TT genotype group
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: TA genotype group
Number of subjects: 29
Study: 20444742

Group type: EXPERIMENTAL
Intervention: Aciclovir 800 mg twice daily for 5 days
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Aciclovir
Number of subjects: 422

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 422
Study: 18091543

Group type: EXPERIMENTAL
Intervention: Computerized algorithm based on maximum flow deflection (F(def))
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Computerized algorithm based on maximum airway pressure deflection (P(def))
Number of subjects: 14
Study: 17243360

Group type: EXPERIMENTAL
Intervention: Pianists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonpianists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 14672295

Group type: COMPARATOR
Intervention: Milk group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Meat group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Energy group
Number of subjects: 0
Study: 10950228

Group type: EXPERIMENTAL
Intervention: Tri-iodothyronine treatment (2 microg/kg bodyweight on day 1, 1 microg/kg bodyweight on subsequent days up to 12 days)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tri-iodothyronine treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 40
Study: 8973709

Group type: EXPERIMENTAL
Intervention: Mitochondrial DNA mutation at nucleotide 1555
Number of subjects: 7
Study: 1282179

Group type: EXPERIMENTAL
Intervention: Nicorandil (10 mg b.i.d. increased to 20 mg b.i.d. after 4 weeks)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Nicorandil (20 mg b.i.d.)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Nifedipine (20 mg b.i.d.)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both treatments (Nicorandil and Nifedipine)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Nicorandil (20 mg)
Number of subjects: 58
Study: 6429850

Group type: EXPERIMENTAL
Intervention: AIO solution (40 g crystalline L-aminoacids, 38 g fat, 75 g sorbitol, 45 g xylitol in 1000 ml)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional TPN (glucose and aminoacids)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: AIO solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional TPN
Number of subjects: 20
Study: 30534946

Group type: EXPERIMENTAL
Intervention: CT-P13
Number of subjects: 5050

Group type: COMPARATOR
Intervention: RP
Number of subjects: 5050
Study: 30399503

Group type: EXPERIMENTAL
Intervention: CBTI with RISE‐UP routine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Psychoeducation (PE)
Number of subjects: 40
Study: 26519435

Group type: EXPERIMENTAL
Intervention: Singing intervention
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Music listening intervention
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Both music interventions
Number of subjects: 89

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 89
Study: 24748778

Group type: EXPERIMENTAL
Intervention: Geriatric Monitoring Unit (GMU)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control
Number of subjects: 320

Group type: COMPARATOR
Intervention: Pre-GMU
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: GMU
Number of subjects: 320
Study: 23322551

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 17
Study: 20536366

Group type: COMPARATOR
Intervention: Conventional amphotericin B at 0.7 mg/kg/day
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B at 3 mg/kg/day
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B at 6 mg/kg/day
Number of subjects: 267
Study: 18685549

Group type: EXPERIMENTAL
Intervention: Heterosexual anal sex activity
Number of subjects: 2357

Group type: EXPERIMENTAL
Intervention: Condom use during anal sex
Number of subjects: 2357

Group type: EXPERIMENTAL
Intervention: Risk behaviors associated with anal sex
Number of subjects: 2357

Group type: EXPERIMENTAL
Intervention: Consistent condom use for anal sex
Number of subjects: 2357
Study: 15619152

Group type: EXPERIMENTAL
Intervention: CD-ROM didactic presentation
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Small-group seminars
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Combined modalities (CD-ROM + small-group seminars)
Number of subjects: 96
Study: 14964349

Group type: EXPERIMENTAL
Intervention: nonretarded test medication
Number of subjects: 18

Group type: COMPARATOR
Intervention: retarded reference formulation
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: both treatments
Number of subjects: 18
Study: 10642807

Group type: EXPERIMENTAL
Intervention: Mobilizing therapy and first transplant
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Mobilizing regimen
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Transplant-related chemotherapy
Number of subjects: 21
Study: 8886748

Group type: EXPERIMENTAL
Intervention: Benfotiamine plus vitamin B6/B12
Number of subjects: 24
Study: 2062997

Group type: EXPERIMENTAL
Intervention: 7 days supply of medication
Number of subjects: 0

Group type: COMPARATOR
Intervention: 14 days supply of medication
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New discharge letter with prescription details
Number of subjects: 0
Study: 2994386

Group type: EXPERIMENTAL
Intervention: 30 Gy/10 fractions/2 weeks
Number of subjects: 69

Group type: COMPARATOR
Intervention: 50 Gy/20 fractions/4 weeks
Number of subjects: 69
Study: 30883177

Group type: EXPERIMENTAL
Intervention: Pre-exposure to Silcton landmarks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control landmarks on the university campus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Familiarity with landmarks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sex differences in direction estimation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perspective taking ability
Number of subjects: 0
Study: 30570797

Group type: EXPERIMENTAL
Intervention: Enhanced supportive supervision of lady health workers (LHWs) by lady health supervisors, including enhanced training on supervisory skills and written feedback.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (comparison arm) with standard supervision without enhanced training or feedback.
Number of subjects: 34
Study: 27160060

Group type: EXPERIMENTAL
Intervention: Performance contingent reward
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-contingent reward
Number of subjects: 0